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Abstract 
Methicillin-resistant Staphylococcus aureus (MRSA) is a multiple drug-resistant 
bacterium, which responsible for nosocomial and community-acquired infection. This 
study compared the mannitol salt agar-oxacillin (MSO), mannitol salt agar-cefoxitin 
(MSC), oxacillin resistance screening agar base (ORSAB), chromogenic agar medium 
(CHROMagar), and MRSA-screen latex agglutination test to mecA PCR method as 
the "gold standard" assay in order to determine the most simple, reliable and cost 
effective test method for diagnostic purpose. 58 MRSA strains were isolated form 144 
samples collected from HUSM. The MSO, MSC, ORSAB, CHROMagar, and 
MRSA-screen gave sensitivity with 94%, 95%, 97%, 95% and 93% respectively, 
specificity with 98%, 87%, 97%, 95% and 99% respectively, positive predictive value 
(PPV) with 98%, 83%, 95%, 93% and 98% respectively, negative predictive value 
(NPV) with 95%, 96%, 98% 97% and 96% respectively, and cost with RM1.24, RM 
1.38, RM 1.42, RM 8.50 and RM 12.50 respectively for one sample. All the test 
methods were agreed with PCR. In conclusion, ORSAB have the highest diagnostic 
value, followed by MSO, MRSA-screen, CHROMagar and lastly MSC. The MSO 
was the cheapest test method, followed by MSC, ORSAB, CHROMagar and then 
MRSA-screen. ORSAB can be the most suitable diagnostic test method with high 
diagnostic test value and low cost. 
Abstrak 
"Methicillin-resistant Staphylococcus aureus" merupakan sejenis bacteria yang 
rintang terhadap pelbagai antibiotik, menyebabkan jangkitan nosocomial dan 
jangkitan "community-acquired". Projek penyelidikan ini membuat perbandingan 
antara UJtan "mannitol salt agar-oxacillin"(MSO), "mannitol salt 
agar-cefoxitin"(MSC), "Oxacillin resistance screening agar base"(ORSAB), 
"chromogenic agar medium"(CHROMagar), dan "MRSA-screen latex agglutination 
test"(MRSA-screen) dengan ujian PCR sebagai kaedah "gold standard". 58 strain 
MRSA telah diperolehi daripada 144 specimen yang didapati dari HUSM. Setelah 
analisis statistik, didapati bahawa MSO, MSC, ORSAB, CHROMagar dan 
MRSA-screen mempunyai sensitiviti 94%, 95%, 97%, 95% dan 93%, spesi:fisiti 98%, 
87%, 97%, 95% dan 99%. Manakala, nilai anggaran positif pula adalah 98%, 83%, 
95%, 93% dan 98%, nilai anggaran negatif 95%, 96%, 98%, 97% dan 96%. Harga 
untuk: setiap ujian adalah RM 1.24, RM 1.38, RM 1.42, RM8.50, dan RM 12.50. 
Sebagai kesimpulan, ORSAB mempunyai nilai diagnostik yang paling tinggi antara 
kelima-lima kaedah ujian, diikuti dengan MSO, MRSA-screen, CHROMagar, dan 
MSC. Kaedah ujian yang paling murah adalah MSO, diikuti dengan MSC, ORSAB, 
CHROMagar dan MRSA-screen. ORSAB boleh menjadi kaedah ujian diagnostik 
yang paling sesuai disebabkan oleh nilai diagnsotik yang tinggi dan harganya yang 
murah. 
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1 Introduction 
1.1 Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus 
(MRS A) 
Staphylococcus aureus is an aerobic or facultative anaerobic, coagulase-positive 
organism. It appears as gram positive clusters on Gram stain. Taxonomically, the 
genus Staphylococcus is in the Bacterial family Staphylococcaceae, which includes 
three lesser known genera, Gamella, Macrococcus and Salinicoccus, most of them 
living as harmless commensalisms on the skin and mucosa of mammals and birds 
(Kenneth, 2005). Staphylococci, however, also belong to the most frequently isolated 
microorganisms in medical microbiology, and Staphylococcus aureus is one of the 
species with the greatest clinical impact. It is an important human pathogen, which is 
responsible for nosocomial and community acquired infections (Karsten et al., 2007; 
Sule et al., 2007). 
Methicillin-resistant Staphylococcus aureus is a multiple antimicrobial 
drug-resistant bacterium (Jayaratne and Ruthrford, 1999). Beside methicillin and most 
other beta-lactam antibiotics, MR.SA strains are also often resistant to other antibiotics 
such as aminoglycosides, tetracyclines and quinolones (Daniel et al., 2007; Fusun et 
al., 2007). 
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1.2 Epidermiology 
The frrst report of a penicillin- resistant strain of S. aureus was published in 1945, 
revealing its association with penicillinase enzyme produced by the bacteria (Spink 
and Ferris, 1945). The development of methicillin antibiotics, synthetic penicilinase 
resistant penicillin, followed within 2 years, S. aureus developed resistance to 
methicillin shortly there after (Stewart and Holt, 1962; Bareett et al., 1968). Since the 
frrst report of methicillin-resistant S. aureus (MRSA) in the UK and Europe in 
the1960, and in the US in 1968, the incidence of infections caused by MRSA has 
continues to increase worldwide (Karsten et al., 2007). It was recognized as an 
important nosocomial infection in the US in the late 1960's. It became endemic in 
some health care setting. The prevalence of MRSA infections varies from 5% to more 
than 50% depending on the characteristics and size of the hospitals. In Malaysia, the 
prevalence of MRSA has increased from 23% in 1991 to 33% in the year 2000. The 
prevalence of MRSA in Hospital Universiti Sains Malaysia (HUSM) was 40.4% in 
year 2003 (Sarimah, 2005). 
1.3 Pathogenesis 
Staphylococcus aureus causes a variety of suppurative (pus-forming) infections 
and toxinoses in humans. It causes superficial skin lesions such as boils, styes and 
furunculosis. It also causes more serious infections such as pneumonia, mastitis, 
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phlebitis, meningitis, and urinary tract infections; and deep-seated infections, such as 
osteomyelitis and endocarditis. It is a major cause of hospital acquired (nosocomial) 
infection of surgical wounds and infections associated with indwelling medical 
devices. S. aureus causes food poisoning by releasing enterotoxins into food, and 
toxic shock syndrome by release of superantigens into the blood stream (Kenneth, 
2005). 
Staphylococcus aureus expresses many potential virulence factors: surface 
proteins that promote colonization of host tissues, invasins that promote bacterial 
spread in tissues (lekocidin, kinases, hyaluronidase), surface factors that inhibit 
phagocytic engulfment (capsule, protein A), biochemical properties that enhance their 
survival in phagocytes ( carotenoids, catalase production), immunological disguises 
(Protein A, coagulase, clotting factor), an~ membrane-damaging toxins that lyse 
eukaryotic cell membranes (hemolysins, leukotoxin, leukocidin), exotoxins that 
damage host tissues or otherwise provoke symptoms of disease (SEA-~ TSST, ET) 
and inherent and acquired resistance to antimicrobial agents (Kenneth, 2005). 
The mechanisms of methicillin resistance in the heterogenous and homogenous 
population ofMRSA are diverse (Lyon and Skunay, 1987; Berger, 1995; Kayser, 1996; 
Araj et al., 1999; Chamber, 1997). Primarily, its strong resistance is a result of its 
penicillin-binding protein 2a, which has a low affinity for beta-lactam antibiotics 
(Berger, 1994). Penicillin-binding protein 2a is encoded by the mecA gene which is in 
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the chromosome of methicillin resistant strains of many staphylococcal species (Lyon 
and Skunay, 1987; Archer and Niemeyer, 1994; Berger, 1995; Kayser, 1996; Chamber, 
1997). Other genes such as fomA, fomB and mecRJ can also contribute to MRSA 
resistance (Lyon and Skunay, 1987; Berger, 1995; Kayser, 1996; Chamber, 1997). 
1.4 The Importance and Challenge for Detection ofMRSA 
Detection of MRSA in clinical sample is very important in diagnostic 
microbiology because bacteremia caused by MRSA increases the length of hospital 
stay, is responsible for rising health care cost, and has a high morbidity and mortality 
rate when compared with bacteremia caused by methicillin-susceptible S. aureus 
(MSSA). Therefore, a rapid and accurate detection of MRSA in clinical sample is 
essential to control the spread of MRSA in the hospital and plays an important role in 
early therapeutic decisions (Sule et al., 2007). 
A wide range of methods has evolved for the detection of MRSA in the clinical 
laboratory (Lee et al., 2004). However, the detection of methicillin resistance in 
clinical microbiology laboratories is stills a considerable challenge to microbiologists 
because of the nature of the resistance. The expression of methicillin resistance is 
affected by different factors including incubation temperature, inoculum size, 
incubation time, salt concentration and a host of other factors. For these reasons, a 
number of conventional test methods have been used to detect accurately methicillin 
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resistance of both S. aureus and coagulase-negative staphylococci, but none has been 
able to detect it in all resistant strains. DNA methods that detect the genes encoding 
methicillin resistance ( mecA) or its product, penicillin-binding protein 2a, are reliable 
and specific, however, they are technically demanding and expensive, which restricts 
their use in research or reference laboratories. Therefore, there is a need to have an 
evaluation of conventional test methods in order to identify the simplest, cost 
effective and reliable test that detects methicillin resistance rapidly (Udo et a/., 2000). 
1.5 Conventional Test Methods 
Several conventional methods, included the automated rapid method are used to 
isolate and identify MRSA. The methods are mannitol salt agar-oxacillin, mannitol 
salt agar-cefoxitin, oxacillin resistance screening agar base (ORSAB), chromogenic 
agar medium(CHROMagar), and MRSA-screen latex agglutination test (Sakoulas et 
al., 2001; Jochen, 2002; Perry et al., 2004; Lee et al., 2004; Smyth and Kahlmeter, 
2005; Louie et al., 2006). 
Mannitol salt agar supplemented with oxacillin ( 4mg/l) and cefoxitin ( 4mg/l) 
were developed as a selective medium for MRSA. Mannitol salt agar-oxacillin is 
widely used method but has shown limited sensitivity and specificity in some studies 
(John et al., 2004). On other hand, cefoxitin has been reported as a better agent for 
prediction of methicillin-resistant in S. aureus (Smyth and Kahlmeter, 2005). Thus, 
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both methods were included in this study for evaluation. A modified version of 
mannitol salt agar, oxacillin resistance screening agar base (ORSAB), is more 
selective due to the presence of lithium chloride and polymyxin and contains aniline 
blue as a pH indicator (Perry et al., 2004). CHROMagar is a chromogenic media 
incorporating chromogenic enzymatic substrate and a variety of antimicrobial agents. 
It has become available for detection of S. aureus, including methicillin-resistant 
strains (Louie et al., 2006). It offered a high degree of sensitivity and specificity 
compared to conventional methods (Perry et al., 2004). Lastly, the MRSA-Screen is a 
rapid and sensitive slide latex agglutination test for the detection ofPBP2a present in 
MRSA. For the test, latex particles sensitized with a monoclonal antibody raised 
against the PBP2a protein agglutinate visibly when mixed with a cell extract of 
methicillin-resistant Staphylococcal strains (Udo et al., 2002). 
All these methods were evaluated and compared to PCR test results for mecA as 
the "gold standard" assay (Sakoulas et al., 2001). Therefore, the objectives of this 
study were: 
1. To isolate the MRSA from the specimen obtain from HUSM 
2. To identify MRSA by using different conventional test methods and PCR 
3. To evaluate the sensitivities, specificities, positive predicted value, and negative 
predicted value of different conventional test for the diagnosis of MRSA 
4. To determine the cost effectiveness of each conventional test methods 
5. To determine the most suitable test method for detection of MRSA 
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2 Review of literature 
For humans, Staphylococcus aureus are important causes of food poisoning, 
pneumonia, wound infection, and nosocomial bacteremia. Staphylococcal isolates are 
frequently resistant to penicillinase-resistant penicillins. Organisms exhibiting this 
type of resistance are referred to as methicillin (oxacillin)-resistant staphylococci 
(MRS). These bacteria are also frequently resistant to most of the commonly used 
antimicrobial agents, including the aminoglycosides, macrolides, chloramphenicol, 
tetracylcline, and fluoroquinolones. In addition, MRS strains should be considered to 
be resistant to all cephalosporins, cephems, and other beta-lactams, such as 
ampicillin-sulbactam, amoxicillin-clavulanic acid, ticarcilin-clavulanic . acid, 
piperacillin-tazobactam, and thecarbapenems, regardless of the invitro test results 
obtained with those agents (Lee et al., 2004 ). 
According to Sarimah (2005), MRSA, one of the major concerns of nosocomial 
infections, is particularly alarming because due to its association with multiple 
resistance to other antibiotics. The current requirement for prolonged parenteral 
antibiotic therapy, particularly intravenous vancomycin for MRSA bacteremia, 
remains a major constant in reducing the length of acute hospitalization and costs of 
patient care. The high treatment costs indicate that the economic burden associated 
with MRSA is substantial and these costs are likely to increase if the rate of MRSA 
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continues to rise further. 
Accurate and rapid identification of MRSA in clinical specimens is essential for 
timely decisions on isolation procedures and effective antimicrobial chemotherapy. 
Early detection of MRSA permits timely implementation of preventive infection 
control strategies and reduces costs. Standard procedures in clinical microbiology lead 
to difficulties in attempting to identify MRSA within time frames that allow routine 
grouping of newly admitted patients. Conventional processing of screening samples 
takes 2 or 3 days. PCR for mecA and femB provides reliable and unequivocal results 
for MRSA identification within 18 hours (Jonas et al., 2002). 
The tube coagulase test is a valid means of identifying S. aureus, provided that 
only a firm clot that does not move when the tube is tipped is consider as a positive 
reaction (Sperber and Tatini, 1975). 
According to Kobayashi et al., (1998), MRSA is defmed by the production of a 
specific penicillin-binding protein (PBP), PBP-2a that has a reduced binding affinity 
for beta-lactam compound. PBP-2a functions as a transpeptidase in cell wall synthesis 
in MRSA at high concentrations of beta-lactam antibiotics that inhibit the growth of 
methicillin susceptible strains with normal PBPs. This additional PBP is encoded by 
the structural gene mecA on the chromosome, which has also been detected in 
methicillin-resistant strains of other staphylococcal species. The mecA gene is a 
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component of a large DNA fragment designated to mec DNA, which is located at the 
specific site of the S. aureus chromosome and has been suggested to be transmitted 
from other bacterial species. The acquisition of mecA DNA is considered to be the 
first genetic requisite for methicillin resistance of Staphylococci. 
The gene encoding the altered PBPs is primarily the mecA gene. Other genes such 
as femA, femB and mecRJ can also contribute to MRSA resistance. However, 
production of the PBP2a, an induced 76kDa PBP that determines methicillin 
resistance, was found to be the most commonly encountered mechanism (Araj et al., 
1999). 
Several conventional methods have been used to detect the MRSA isolates 
including the 1 mg oxacillin disk diffusion test, agar plate screen, the micro broth 
dilution and the E-tests. To enhance detection of methicillin resistant Staphylococcus 
isolates, most of these methods include media supplemented with sodium chloride. 
The reliability of these conventional methods is reported to be between 80 to 95%; 
results can only be read 24h after pure colonies of the organism have been obtained 
(Araj et al., 1999). 
Low-level MRSA colonization may be missed due to the overgrowth of normal 
flora. However, by using selective media, it is possible to increase the rate of recovery 
of MRSA isolates. Mannitol salt agar (MSA) supplemented with oxacillin as well as 
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oxacillin resistance screening agar base (ORSAB) rendered more selective by the 
presence of lithium chloride and polymycin, and containing aniline blue as a pH 
indicator are widely used. However, these media have shown limited sensitivity and 
specificity in several studies. The lack of sensitivity is due in part to the delay in the 
expression of oxacillin resistance, which explains why these media perform well only 
after 48h of incubation (Nsira et al., 2006) 
Smyth and Kahlmeter (2005) showed that the cefoxitin is a better agent for 
prediction of methicillin resistance inS. aureus, and disk susceptibility testing with 
cefoxitin now replaces disk susceptibility testing with methicillin and oxacillin in an 
increasing number of centers. Their results demonstrate that cefoxitin is far superior 
to oxacillin when it is used in this particular mannitol salt medium. By the use of 48h 
incubation and 102 -CFU/ml inoculum, the sensitivity and specificity of the cefoxitin 
MSA plate method were 100% (compared to 90.7% with oxacillin) and 100% 
(compared to 96.0% for oxacillin), respectively, when the comparison was made for 
the strains used in both studies. Mannitol-salt agar with cefoxitin appears to be 
superior for MRSA screening, probably because cephamycins are better inducers of 
PBP2a (Smyth and Kahlmeter, 2005). 
Several factors contribute to the successful isolation of MRSA on selective media. 
These include the ability of the medium to support the growth of MRSA, the 
sensitivity of the indicator system, and the effective inhibition of the competing 
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bacterial flora. The results for pure control strains at small inocula suggest that 
cefoxitin may be a superior selective agent to oxacillin with respect to the growth of 
MRSA. The author also reported that a concentration of 4mg of cefoxitin/liter allowed 
the growth of all MRSA strains and the inhibition of all MSSA strains (Lee et al., 
2004). 
Since methicillin resistance can be found both in S. aureus and 
coagulase-negative Staphylococci (CoNS), rapid identification of S. aureus is required 
in addition to the detection of methicillin resistance. For this purpose, the use of 
media containing chromogenic enzyme substrates has been proposed. Studies have 
reported adaption of CHROMagar S. aureus for the specific isolation of MRSA by the 
inclusion of methicillin or oxacillin. These media were tested with strains of MRSA 
from collection and were found to be specific, but again more sensitive after 48h 
compared with 24h of incubation (Nsira et al., 2006). Genetic confirmation of 
positive findings based on detection of the mecA gene has also been reported (Lee et 
al., 2004). 
MRSA-Screen is a rapid slide latex agglutination assay produced by Denka 
Seik:en Co. Ltd. (Tokyo, Japan). It detects the PBP2a of methicillin-resistant 
staphylococci where the results showed that MRSA-Screen detected PBP2a 
accurately in all MRSA isolates tested. It correctly identified the MRSA an isolate 
classified as intermediate resistant by conventional disk diffusion method. 
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Furthermore, it correctly classified all MSSA isolates as methicillin susceptible with 
no false positive results. Results of the MRSA-Screen for MRSA isolates agreed with 
those obtained with mecA PCR and the conventional methods, making it a very 
reliable method for detecting methicillin resistance in S. aureus (Udo et al., 2000). 
The MRSA-Screen latex agglutination test for PBP2a was easy to perform, gave 
results rapidly (15 to 20 min), was amenable to the processing of large numbers of 
samples, and approached the accuracy of PCR for mecA with respect to sensitivity 
(100%) and specificity (99.1%). Induction ofPBP2a by beta-lactam (cefoxitin) seems 
to increase the sensitivity of the MRSA-Screen latex agglutination test, especially 
with coagulase-negative staphylococci (Sakalous et al., 200 I). 
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3 Materials and Methods 
3.1 Sample Size Determination 
The sample size of this study was calculated by using the following formula: 
Where, 
Sample size= Z2Cp)(l-p) 
c2 
= 1.962 (0.4)(1-0.4) 
0.082 
= 144 
Z = Z value (e.g. 1.96 for 95% confidence level) 
p = percentage picking a choice, expressed as decimal 
c = confidence interval, expressed as decimal 
Thus, the total of sample that needed to be collected was 144. 
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3.2 Sample Collection. 
3.2.1 Materials 
Contents Amount 
Peptone water IOml 
Sterile swab lpc 
Table 3.1 List of materials for sample collection 
3.2.2 Methods 
There are mainly two sources of sample included in this study. 40 MRSA samples 
were collected from Medical Microbiology and Parasitology Laboratory's stock in 
HUSM. These MRSA isolates were recovered from colonies on Mullen Hinton Agar 
for susceptibility testing which diagnosed as !vfRSA positive. A total of 104 clinical 
samples were collected from different wads in HUSM. The samples were obtained 
from the nasal swab of patients, relative of patient and staff nurse in the ward. Then, 
the swabs media were kept in the bottle that contains peptone water as preservative 
and transported to the research lab for further processing immediately. Isolates were 
characterized as MRSA by several test method as described below. ATCC 43300 
standard strains were used as positive control strains for S. aureus. ATCC 33591 
standard strains were used as positive control strain for :MRSA. 
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